Pharma is up and banking is down this week.
GlaxoSmithKline (GSK) had a stellar week with a 4% gain, however they were only on 0.1% before this so the 4.1% year to date does not move them from 17th.
While AstraZeneca (AZN) were close behind for the week with 3.9% gain, moving them from 10th to 7th. Both now profiting from ongoing Covid vaccinations, GSK being a lot later to the party than AZN accounts for the big difference in league position. Full Story
HSBC (HSBA) had it worse this week suffering a 2.1% loss thanks to Moody’s downgrading their senior unsecured debt rating to A3 from A2 and their top Asia executive announcing retirement.
Lloyds Banking (LLOY) were close behind losing 1.9% although this may be short-lived with Barclays forecasting a higher share price for Lloyds.
A shorter analysis this week but I’m not going to hold on to what you can take from this weeks action.
What can entrepreneurs take from this weeks movements?
- Have you thought about succession planning? For yourself and other key members of your team?
- Have you thought about partnerships to access current trends/booming markets?
- Have you thought about how others value your company / assets / liabilities? Could you work with someone to do an external viewpoint of your businesses strengths, weaknesses, opportunities and threats?
Now to the all important league table.
|9||Rio Tinto PLC||-1.7%||10.9%|
|11||Royal Dutch Shell A||1.4%||9.5%|
|12||Royal Dutch Shell B||1.4%||7.6%|
|13||Vodafone Group PLC||1.7%||7.3%|
|16||British American Tobacco||3.0%||4.4%|
|20||London Stock Exchange||1.8%||-15.9%|
Who is going to lose it all?
Who is going to recover?
What do you think? Let us know in the comments.
Until next week.